Chemico-biological interactions · 2026
Isopsoralen-induced hepatotoxicity: The regulatory role of endoplasmic reticulum stress-triggered mitochondrial dysfunction and apoptosis.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Yuan Mingxin, Han Yiping, Lou Pengshuo, Wang Chen, Zhou Kun, Zhang Yue, Yu Yingli
Аннотация
OBJECTIVE: Fructus Psoraleae is a commonly used herb in traditional Chinese medicine, widely applied in the treatment of osteoporosis, vitiligo, and other diseases. Isopsoralen, as the core active component of Fructus Psoraleae, possesses both pharmacological effects and toxic risks, among which hepatotoxicity is a key issue limiting its safe clinical application. Currently, the molecular mechanism underlying isopsoralen-induced liver injury has not been fully elucidated. This study investigates isopsoralen-induced liver injury, focusing on the interaction between endoplasmic reticulum stress (ERS) and mitochondrial dysfunction.
RESULTS: In HepG2 cells, isopsoralen dose- and time-dependently reduced survival and increased lactate dehydrogenase release. In mice, isopsoralen elevated serum aminotransferases and creatine kinase. RNA sequencing revealed differential gene expression related to ERS and mitochondria. Isopsoralen increased the ERS markers glucose-regulated protein 78 and C/EBP homologous protein in vitro. Co-treatment with the ERS inhibitor 4-phenylbutyrate reduced caspase expression and apoptotic proteins while increasing the anti-apoptotic protein Bcl-2 in mouse liver tissue. 4-phenylbutyric acid also restored the mitochondrial fusion/fission balance, increased adenosine triphosphate content, and attenuated oxidative stress.
CONCLUSION: Isopsoralen induces ERS, activating downstream apoptotic pathways that lead to mitochondrial dysfunction and subsequent liver injury. Inhibiting ERS alleviates this hepatotoxicity by improving mitochondrial dynamics and reducing oxidative stress.
RESULTS: In HepG2 cells, isopsoralen dose- and time-dependently reduced survival and increased lactate dehydrogenase release. In mice, isopsoralen elevated serum aminotransferases and creatine kinase. RNA sequencing revealed differential gene expression related to ERS and mitochondria. Isopsoralen increased the ERS markers glucose-regulated protein 78 and C/EBP homologous protein in vitro. Co-treatment with the ERS inhibitor 4-phenylbutyrate reduced caspase expression and apoptotic proteins while increasing the anti-apoptotic protein Bcl-2 in mouse liver tissue. 4-phenylbutyric acid also restored the mitochondrial fusion/fission balance, increased adenosine triphosphate content, and attenuated oxidative stress.
CONCLUSION: Isopsoralen induces ERS, activating downstream apoptotic pathways that lead to mitochondrial dysfunction and subsequent liver injury. Inhibiting ERS alleviates this hepatotoxicity by improving mitochondrial dynamics and reducing oxidative stress.